Cellosaurus RT112/D21 (CVCL_6215)

Cell line name RT112/D21
Synonyms RT-112-D21
Accession CVCL_6215
Resource Identification Initiative To cite this cell line use: RT112/D21 (RRID:CVCL_6215)
Comments Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Disease Bladder carcinoma (NCIt: C4912)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1670 (RT-112)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): CLS

Markers:
AmelogeninX
CSF1PO10,11
D13S31713,14
D16S53911,13
D18S5115
D21S1127,30
D3S135815
D5S81810,13
D7S82011,12
D8S117913,15
FGA23
Penta D10,11
Penta E12,16
TH017
TPOX8,11
vWA14,17
Publications

PubMed=7740654; DOI=10.1007/BF00296874
Seemann O., Muscheck M., Siegsmund M., Pilch H., Nebe C.T., Rassweiler J., Alken P.
Establishment and characterization of a multidrug-resistant human bladder carcinoma cell line RT112/D21.
Urol. Res. 22:353-360(1995)

Cross-references
Cell line collections CLS; 300325/p458_RT-112-D21